Cargando…
Anti-glycolipid disorder effect of epigallocatechin-3-gallate on high-fat diet and STZ-induced T2DM in mice
Epigallocatechin-3-gallate (EGCG) is beneficial for inhibiting dyslipidemia and reducing hyperlipidemic risk. The purpose of the present study was to investigate the glycolipid regulatory effects and potential mechanisms of EGCG in a high-fat diet and streptozotocin-induced type 2 diabetes mellitus...
Autores principales: | Ren, Zhongkun, Yang, Zhiyong, Lu, Yi, Zhang, Rongping, Yang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185284/ https://www.ncbi.nlm.nih.gov/pubmed/32236613 http://dx.doi.org/10.3892/mmr.2020.11041 |
Ejemplares similares
-
Epigallocatechin-3-Gallate Reduces Fat Accumulation in Caenorhabditis elegans
por: Liu, Jinning, et al.
Publicado: (2018) -
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice
por: Moreno, Mayara Franzoi, et al.
Publicado: (2014) -
In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
por: Wang, Wang, et al.
Publicado: (2019) -
Amelioration of cognitive impairment using epigallocatechin-3-gallate in ovariectomized mice fed a high-fat diet involves remodeling with Prevotella and Bifidobacteriales
por: Qu, Yang, et al.
Publicado: (2023) -
Effects of (−)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet
por: Zhou, Jihong, et al.
Publicado: (2018)